Follow Us :

Global Transplant Diagnostics Market By Product Type (Instrument, Software and Reagent), By Technology (Molecular Assay Technologies and Non-Molecular Assay Technologies), By Transplant Type (Solid Organ Transplantation, Stem Cell Transplantation, Soft Tissue Transplantation and Bone Marrow Transplantation), By Application (Pre-Transplantation Diagnostics and Post-Transplantation Diagnostics), By End-User (Research Laboratories and Academic Institutes, Hospitals and Transplant Centres and Commercial Service Providers), By Geography, North America (U.S., Canada) South America (Mexico, Brazil, Argentina, Columbia, Rest of South America) Europe (Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific) Middle East and Africa (Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa) Trends and Forecast till 2028

Report ID: HC0921TD | Published Date: Sept-2021 | Category: Healthcare Technology | Base Year: 2023 | Format: Report Formats

The Transplant Diagnostics market is expected to reach over USD 6.4 Billion by 2028 exhibiting a CAGR of 7.5% during the forecast period of 2021 to 2028. Phoenix Research Study on the transplant diagnostics market provides insight and analysis regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth.

Transplant Diagnostics Market: Insight and Analysis
The term “transplant diagnostics” refers to a diagnostic technique that is performed before and after a transplant. It aids in the evaluation of the patient’s health. If not avoided, a person with low immunity risks contracting HAIs or worse, which could be fatal. The method is believed to be a collaborative effort between healthcare professionals and laboratory experts that results in better patient outcomes.

Global Transplant Diagnostics Market

The demand for Transplant Diagnostics is gaining enormous prominence and promising exponential growth. One of the primary factors driving the growth of the transplant diagnostics market is the increase in the number of organ transplants performed around the world. The disparity between organ demand and availability, which is always greater than supply, accelerates the expansion of the transplant diagnostics market. The transplant diagnostics market is also influenced by an increased preference for preventative care testing, public awareness regarding organ donation and transplantation, and an increase in the incidences of infectious illnesses such as COVID-19.

This transplant diagnostics report discusses the market potential and trends, opportunities, untapped and emerging revenue pockets, year-on-year growth analysis, market revenue, application and user behavior, competitor analysis, local and major player impact and heat mapping, landscape, recent strategic activities, trade data, import-export data, supply and demand analysis, production and value chain brand share, company market share and ranking analysis, the impact of covid 19 and regulatory changes, technology roadmap, application niches, and so on.

Phoenix research consultants use their proprietary research methodology to evaluate data that involves data mining, analysis of the impact of data variables on the market, and primary validation. Furthermore, other data models consist of a market overview and guide, company matrix, key intensity vendor mapping, market forecasting analysis, company share analysis, top-down and bottom-up analysis, and others.

Transplant Diagnostics Market – Pre and Post-Covid Analysis
The coronavirus disease (COVID-19) pandemic outbreak has created extreme uncertainty in the market growth globally. The pandemic outbreak has affected and changed the complete dynamics of the Transplant Diagnostics market in ways that are hard to believe. The efficacy and intensity of containment efforts to the extent of supply disruptions, shifts in spending patterns, behavioral changes (such as avoiding purchasing), the repercussions of the dramatic tightening in global market conditions, confidence effects, volatile commodity prices, and increasing debt burdens. Due to COVID-19, all the countries have faced a multi-layered crisis comprising domestic economic disruptions, plummeting external demand, collapse in the prices, and collapse in supply and demand of the products across the globe.

According to the United Nations, in 2020, the global economy could shrink by almost 1% due to the impact of the COVID-19 pandemic. The COVID-19 pandemic outbreak has created extreme uncertainty in the Transplant Diagnostics market growth around the globe. The COVID-19 outbreak from December 2019 has impacted more than 100 countries across the globe and significantly it has mainly impacted the Transplant Diagnostics market in 2020. The pandemic has affected the overall medical device in different ways as demand for some of the products/services has increased, but due to supply chain market disruption, manufacturing was not able to fulfill the order resulting in a financial impact on the vendors.

Contact for more details on Pre and post COVID-19 impact on supply and demand, price, manufacturer/provider, and End-use industry among others.

Transplant Diagnostics Market: Study Scope and Market Engineering
The transplant diagnostics market is divided into five categories: product type, technology, transplant type, application, and end-user. The growth among segments allows you to analyze potential revenue pockets of growth and market as well as determine core competencies in your target markets.
• The Transplant Diagnostics market is segmented on the basis of the product type into the instrument, software, and reagent.
• The Transplant Diagnostics market is segmented on the basis of the technology into molecular assay technologies and non-molecular assay technologies. Molecular assay technologies are further segmented into PCR-based molecular assays and sequencing-based molecular assays. PCR-based molecular assays are sub-segmented into real-time PCR, sequence-specific primer-PCR, sequence-specific oligonucleotide-PCR, and other PCR-based molecular assays. Sequencing-based molecular assays are further segmented into Sanger sequencing, next-generation sequencing, and other sequencing-based molecular assays.
• The Transplant Diagnostics market is segmented on the basis of the transplant type into solid organ transplantation, stem cell transplantation, soft tissue transplantation, and bone marrow transplantation.
• The Transplant Diagnostics market is segmented on the basis of the application into pre-transplantation diagnostics, and post-transplantation diagnostics. Pre-transplantation diagnostics are further segmented into infectious disease testing, histocompatibility testing, and blood profiling.
• The Transplant Diagnostics market is segmented on the basis of the end-user into research laboratories and academic institutes, hospitals, and transplant centers, and commercial service providers.

Transplant Diagnostics Market: Geographical Coverage and Analysis
The countries covered in the transplant diagnostics market report are U.S. and Canada in North America, Brazil, Mexico, Columbia, and the Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore and Rest of Asia-Pacific in the Asia-Pacific, GCC countries, South Africa, Rest of Middle East and Africa as a part of Middle East and Africa.

North America holds the largest market share in global transplant diagnostics followed by Europe and the Asia Pacific region. Due to rising technological advancements and the high adoption of transplant diagnostics in the region, the United States dominates the North American market. In addition, the region has a well-established infrastructure, which allows for the quicker deployment of new technology.

Individual market-affecting factors and changes in regulation in the domestic market are also discussed in the report, which has an impact on the market’s current and future developments. Top-down and bottom-up value chain analysis, trends, Macro and Microeconomic indicators, Pestle and Porter’s five forces tools, and case studies are only a few of the data sources used to anticipate the market scenario for different countries. Additionally, while offering forecast analysis of the country data, the presence and availability of global brands, as well as the obstacles they face owing to significant or scarce competition from local and domestic brands, the influence of domestic tariffs, and trade routes are all taken into account.

Transplant Diagnostics Market: Competitive Insights:
The global transplant diagnostics market is highly competitive, and major players have used various approaches to raise their footprints in this market such as new product advancements, acquisitions, contracts, joint ventures, alliances, acquisitions, and others. The scope of the study includes Transplant Diagnostics market revenue for Global, Asia-Pacific, North America, Europe, South America, and the Middle East & Africa. Company overview, financials, revenue analysis, market potential, research and development, strategic initiatives, company footprint, strengths and weaknesses, product launch, product width and breadth, and application dominance are all included in the details. The data points presented above are solely related to the companies’ focus on the Transplant Diagnostics markets for the retail industry.

The major players covered in the transplant diagnostics market report are Cylex Inc., LXN Corporation, Alpha Laboratories, Horiba Medical, Laboratory Corporation of America Holdings, F. Hoffmann-La Roche Ltd., Randox Laboratories Ltd, Thermo Fisher Scientific Inc., Otsuka Holdings Co Ltd., Medtronic, Novartis AG, Pfizer Inc., Sanofi, Terumo Corporation, Preservation Solutions, Inc., TransMedics, Inc., Transonic, AbbVie Inc., Stryker, Zimmer Biomet, NHS Blood, and Transplant among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South America separately. Pheonix research understands competitive strengths and provides competitive analysis for each competitor separately.

Transplant Diagnostics Market Segmentation:
By Product Type
• Instrument
• Software
• Reagent

By Technology
• Molecular Assay Technologies
o PCR-Based Molecular Assays
 Real-Time PCR
 Sequence-Specific Primer-PCR
 Sequence-Specific Oligonucleotide-PCR

 Other

o Sequencing-Based Molecular Assays
 Sanger Sequencing
 Next-Generation Sequencing
 Other

• Non-Molecular Assay Technologies

By Transplant Type
• Solid Organ Transplantation
• Stem Cell Transplantation
• Soft Tissue Transplantation
• Bone Marrow Transplantation

By Application
• Pre-Transplantation Diagnostics
• Post-Transplantation Diagnostics

By End-User
• Research Laboratories and Academic Institutes
• Hospitals and Transplant Centers
• Commercial Service Providers
• General Medical and Surgical Hospitals

By Geography
• North America
o U.S.
o Canada

• Europe
o Germany
o Italy
o U.K.
o France
o Spain
o Netherlands
o Belgium
o Switzerland
o Russia
o Poland
o Turkey
o Rest Europe

• Asia-Pacific
o Japan
o China
o India
o South Korea
o Taiwan
o Rest of Asia-Pacific

• South America
o Mexico
o Brazil
o Argentina
o Rest of Latin America

• Middle East and Africa
o GCC Countries
o South Africa
o North Africa
o Egypt
o Rest of Middle East and Africa

Request TOC
Please request TOC of this report from here
Please enable JavaScript in your browser to complete this form.

      Licence Options